Atlas Trials

Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC

Clinical trial NCT07480382 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07480382
Sponsor
Hong Wu
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Initially Unresectable Hepatocellular Carcinoma
Start date
2026-04-01
Primary completion
2027-12-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.